RARA CRAFT DATABASE for FDA Medical Devices
510(k)K191831

FDA DEVICE FACTS

MobiliT Cup

Corin U.S.A. Limited

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEJanuary 16, 2020PRODUCT CODELZO

Indications for use

The MobiliTTM Cup, for cemented and cementless use, are indicated for primary replaceme nt of the hip joint:

- In degenerative pathologies: primary, secondary or post-traumatic ost eoarthritis, rheumatoid arthritis

- For patients who have a high risk of dislocation

- In cases of necrosis of the femoral head

- In cases of fracture of the neck of the femur

- In cases of congenital luxation The MobiliTTM Cup, for cemented and cementless use, are indicated for revision when the bone tissue remains sufficient after the removal of the previous acetabular cup. The cementless MobiliT TM standard Cup, with flanges or with flanges and hook are indicated for cementless use only. The cemented MobiliT TM Cup is indicated for cemented use only.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 24, 2026